Mihai Azimioara

A small molecule–kinase interaction map for clinical kinase inhibitors

Miles A. Fabian, William Biggs, Daniel K. Treiber et al. · Nature Biotechnology · 2005 · 1.9K citations · Full text

Pharmacy, Medicinal Chemistry, Molecular Biology +12

The origin of greater than 200:1 enantioselectivity in a catalytic Diels-Alder reaction as revealed by physical and chemical studies

E. J. Corey, Teck‐Peng Loh, Thomas D. Roper et al. · Journal of the American Chemical Society · 1992 · 169 citations

Natural Sciences, Chemistry, Catalysis +5

Structure-based design of an osteoclast-selective, nonpeptide Src homology 2 inhibitor with <i>in vivo</i> antiresorptive activity

William C. Shakespeare, Michael G. Yang, Regine S. Bohacek et al. · Proceedings of the National Academy of Sciences · 2000 · 133 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +17

X-Ray crystal structure of a chiral oxazaborolidine catalyst for enantioselective carbonyl reduction

E. J. Corey, Mihai Azimioara, Sepehr Sarshar · Tetrahedron Letters · 1992 · 100 citations

Natural Sciences, Chemistry, Medicinal Chemistry +16

A hypothesis for conformational restriction in complexes of formyl compounds with boron Lewis acids. Experimental evidence for formyl CH--O and CH--F hydrogen bonds

E. J. Corey, Jeffrey J. Rohde, Axel Fischer et al. · Tetrahedron Letters · 1997 · 86 citations

Natural Sciences, Biochemistry, Chemistry +15